Incubating cardiomyocytes with insulin induces a dose-dependent increase in Hsp60 levels; this protein increases IGF-1 receptor expression and activity, and Hsp60 downregulation has been proposed to be a relevant mechanism for diabetic cardiomyopathy development [80, 81]. The gene discussed is INS; the disease is diabetic cardiomyopathy.